Arbutus Biopharma Corp Research and Development Expense
Arbutus Biopharma Corp (ABUS) reported Research and Development Expense of $2.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-12
CAD
| Period end | Research and Development Expense 12 month |
|---|---|
| 2012-12-31 | 18.03M CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 19.90M CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 22.13M CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | 17.76M CAD 20-F · filed 2012-03-27 |
USD
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.90M 10-Q · filed 2026-08-12 | $7.02M 10-Q · filed 2026-08-12 | $12.02M derived: sum of 3 quarters · filed 2026-08-12 | $17.80M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $4.12M 10-Q · filed 2026-05-13 | $9.13M derived: sum of 2 quarters · filed 2026-05-13 | $14.90M derived: sum of 3 quarters · filed 2026-05-13 | $20.40M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $10.78M derived: sum of 2 quarters · filed 2026-03-23 | $16.28M derived: sum of 3 quarters · filed 2026-08-12 | $25.24M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $5.78M 10-Q · filed 2025-11-13 | $11.28M derived: sum of 2 quarters · filed 2026-08-12 | $20.23M 10-Q · filed 2025-11-13 | $29.05M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $5.50M 10-Q · filed 2026-08-12 | $14.46M 10-Q · filed 2026-08-12 | $23.27M derived: sum of 3 quarters · filed 2026-08-12 | $37.54M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $8.96M 10-Q · filed 2026-05-13 | $17.77M derived: sum of 2 quarters · filed 2026-05-13 | $32.04M derived: sum of 3 quarters · filed 2026-05-13 | $47.59M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $8.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $23.08M derived: sum of 2 quarters · filed 2026-03-23 | $38.63M derived: sum of 3 quarters · filed 2026-03-23 | $54.04M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $14.27M 10-Q · filed 2025-11-13 | $29.82M derived: sum of 2 quarters · filed 2025-11-13 | $45.23M 10-Q · filed 2025-11-13 | $62.79M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $15.55M 10-Q · filed 2025-08-06 | $30.95M 10-Q · filed 2025-08-06 | $48.52M derived: sum of 3 quarters · filed 2025-08-06 | $68.69M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $15.40M 10-Q · filed 2025-05-14 | $32.97M derived: sum of 2 quarters · filed 2025-05-14 | $53.14M derived: sum of 3 quarters · filed 2025-05-14 | $70.83M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $17.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $37.73M derived: sum of 2 quarters · filed 2025-03-27 | $55.42M derived: sum of 3 quarters · filed 2025-03-27 | $73.70M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $20.17M 10-Q · filed 2024-11-06 | $37.86M derived: sum of 2 quarters · filed 2024-11-06 | $56.14M 10-Q · filed 2024-11-06 | $79.08M derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | $17.69M 10-Q · filed 2024-08-08 | $35.97M 10-Q · filed 2024-08-08 | $58.92M derived: sum of 3 quarters · filed 2024-08-08 | $78.97M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $18.27M 10-Q · filed 2024-05-02 | $41.22M derived: sum of 2 quarters · filed 2024-05-02 | $61.28M derived: sum of 3 quarters · filed 2024-05-02 | $84.22M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $22.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $43.00M derived: sum of 2 quarters · filed 2024-03-05 | $65.95M derived: sum of 3 quarters · filed 2024-03-05 | $84.41M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $20.05M 10-Q · filed 2023-11-07 | $43.00M derived: sum of 2 quarters · filed 2023-11-07 | $61.46M 10-Q · filed 2023-11-07 | $80.67M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $22.94M 10-Q · filed 2023-08-03 | $41.40M 10-Q · filed 2023-08-03 | $60.62M derived: sum of 3 quarters · filed 2023-08-03 | $77.33M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $18.46M 10-Q · filed 2023-05-04 | $37.67M derived: sum of 2 quarters · filed 2023-05-04 | $54.38M derived: sum of 3 quarters · filed 2023-05-04 | $70.18M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $19.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $35.92M derived: sum of 2 quarters · filed 2023-03-02 | $51.72M derived: sum of 3 quarters · filed 2023-03-02 | $65.50M 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $16.71M 10-Q · filed 2022-11-09 | $16.30M 10-Q · filed 2021-11-04 | $32.51M derived: sum of 2 quarters · filed 2022-11-09 | $46.29M 10-Q · filed 2022-11-09 | $45.06M 10-Q · filed 2021-11-04 | $62.68M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $15.80M 10-Q · filed 2022-08-04 | $15.40M 10-Q · filed 2021-08-05 | $29.58M 10-Q · filed 2022-08-04 | $28.77M 10-Q · filed 2021-08-05 | $45.97M derived: sum of 3 quarters · filed 2022-08-04 | $58.04M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $13.78M 10-Q · filed 2022-05-05 | $13.37M 10-Q · filed 2021-05-05 | $30.17M derived: sum of 2 quarters · filed 2022-05-05 | $42.24M derived: sum of 3 quarters · filed 2022-05-05 | $52.70M derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $16.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $28.46M derived: sum of 2 quarters · filed 2022-03-03 | $38.92M derived: sum of 3 quarters · filed 2022-03-03 | $49.34M 10-K · filed 2022-03-03 | $47.48M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $12.06M 10-Q · filed 2021-11-04 | $22.53M derived: sum of 2 quarters · filed 2021-11-04 | $32.95M 10-Q · filed 2021-11-04 | $45.36M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $10.46M 10-Q · filed 2021-08-05 | $20.88M 10-Q · filed 2021-08-05 | $33.30M derived: sum of 3 quarters · filed 2021-08-05 | $51.03M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $10.42M 10-Q · filed 2021-05-05 | $22.83M derived: sum of 2 quarters · filed 2021-05-05 | $40.56M derived: sum of 3 quarters · filed 2021-05-05 | $53.30M derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2019-12-31 | $12.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $30.15M derived: sum of 2 quarters · filed 2021-03-04 | $42.89M derived: sum of 3 quarters · filed 2021-03-04 | $57.60M 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | $17.73M 10-Q · filed 2020-11-05 | $30.47M derived: sum of 2 quarters · filed 2020-11-05 | $45.18M 10-Q · filed 2020-11-05 | $56.25M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $12.74M 10-Q · filed 2020-08-07 | $27.45M 10-Q · filed 2020-08-07 | $38.52M derived: sum of 3 quarters · filed 2020-08-07 | $55.08M derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | $14.71M 10-Q · filed 2020-05-11 | $25.77M derived: sum of 2 quarters · filed 2020-05-11 | $42.34M derived: sum of 3 quarters · filed 2020-05-11 | $58.70M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $11.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $27.63M derived: sum of 2 quarters · filed 2020-03-05 | $43.98M derived: sum of 3 quarters · filed 2020-03-05 | $57.93M 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | $16.57M 10-Q · filed 2019-11-06 | $32.92M derived: sum of 2 quarters · filed 2019-11-06 | $46.87M 10-Q · filed 2019-11-06 | $64.69M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | $16.36M 10-Q · filed 2019-08-05 | $30.30M 10-Q · filed 2019-08-05 | $48.13M derived: sum of 3 quarters · filed 2019-08-05 | $63.66M derived: sum of 4 quarters · filed 2019-08-05 | ||||
| 2018-03-31 | $13.95M 10-Q · filed 2019-05-06 | $31.77M derived: sum of 2 quarters · filed 2019-05-06 | $47.31M derived: sum of 3 quarters · filed 2019-05-06 | $62.75M derived: sum of 4 quarters · filed 2019-05-06 | ||||
| 2017-12-31 | $17.82M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $33.36M derived: sum of 2 quarters · filed 2019-03-07 | $48.80M derived: sum of 3 quarters · filed 2019-03-07 | $62.68M 10-K · filed 2019-03-07 | ||||
| 2017-09-30 | $15.54M 10-Q · filed 2018-11-07 | $30.98M derived: sum of 2 quarters · filed 2018-11-07 | $44.85M 10-Q · filed 2018-11-07 | $62.01M derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $15.45M 10-Q · filed 2018-08-03 | $29.32M 10-Q · filed 2018-08-03 | $46.47M derived: sum of 3 quarters · filed 2018-08-03 | $62.21M derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | $13.87M 10-Q · filed 2018-05-04 | $31.03M derived: sum of 2 quarters · filed 2018-05-04 | $46.77M derived: sum of 3 quarters · filed 2018-05-04 | $61.98M derived: sum of 4 quarters · filed 2018-05-04 | ||||
| 2016-12-31 | $17.16M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $32.89M derived: sum of 2 quarters · filed 2018-03-16 | $48.11M derived: sum of 3 quarters · filed 2018-03-16 | $61.25M 10-K · filed 2018-03-16 | ||||
| 2016-09-30 | $15.74M 10-Q · filed 2017-11-02 | $30.95M derived: sum of 2 quarters · filed 2017-11-02 | $44.10M 10-Q · filed 2017-11-02 | $59.00M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $15.21M 10-Q · filed 2017-08-03 | $28.36M 10-Q · filed 2017-08-03 | $43.26M derived: sum of 3 quarters · filed 2018-03-16 | $59.62M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $13.14M 10-Q · filed 2017-05-04 | $28.05M derived: sum of 2 quarters · filed 2018-03-16 | $44.40M derived: sum of 3 quarters · filed 2018-03-16 | $54.09M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $31.26M derived: sum of 2 quarters · filed 2018-03-16 | $40.95M derived: sum of 3 quarters · filed 2018-03-16 | $51.51M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $16.35M 10-Q · filed 2016-11-03 | $26.04M derived: sum of 2 quarters · filed 2016-11-03 | $36.60M 10-Q · filed 2016-11-03 | $48.50M derived: sum of 4 quarters · filed 2017-03-22 | ||||
| 2015-06-30 | $9.69M 10-Q · filed 2016-08-04 | $20.25M 10-Q · filed 2016-08-04 | $32.15M derived: sum of 3 quarters · filed 2017-03-22 | $41.46M derived: sum of 4 quarters · filed 2017-03-22 | ||||
| 2015-03-31 | $10.56M 10-Q · filed 2016-05-04 | $22.46M derived: sum of 2 quarters · filed 2017-03-22 | $31.77M derived: sum of 3 quarters · filed 2017-03-22 | $41.07M derived: sum of 4 quarters · filed 2017-03-22 | ||||
| 2014-12-31 | $11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $21.21M derived: sum of 2 quarters · filed 2017-03-22 | $30.51M derived: sum of 3 quarters · filed 2017-03-22 | $38.71M 10-K · filed 2017-03-22 | ||||
| 2014-09-30 | $9.31M 10-Q · filed 2015-11-05 | $18.61M derived: sum of 2 quarters · filed 2015-11-05 | $26.81M 10-Q · filed 2015-11-05 | $33.78M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2014-06-30 | $9.30M 10-Q · filed 2015-08-07 | $17.50M 10-Q · filed 2015-08-07 | $24.47M derived: sum of 3 quarters · filed 2016-03-09 | $29.98M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2014-03-31 | $8.20M 10-Q · filed 2015-05-06 | $15.18M derived: sum of 2 quarters · filed 2016-03-09 | $20.68M derived: sum of 3 quarters · filed 2016-03-09 | $25.59M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2013-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $12.48M derived: sum of 2 quarters · filed 2016-03-09 | $17.39M derived: sum of 3 quarters · filed 2016-03-09 | $21.46M 10-K · filed 2016-03-09 | $21.46M 6-K · filed 2014-03-06 | |||
| 2013-09-30 | $5.51M 10-Q · filed 2014-11-07 | $10.42M derived: sum of 2 quarters · filed 2014-11-07 | $14.49M 10-Q · filed 2014-11-07 | |||||
| 2013-06-30 | $4.91M 10-Q · filed 2014-08-14 | $8.98M 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | $4.07M 10-Q · filed 2014-05-14 | |||||||
| 2012-12-31 | $18.04M 10-K · filed 2015-03-13 | $18.04M 6-K · filed 2014-03-06 | ||||||
| 2011-12-31 | $20.13M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |